Research graph
References from Comparison of Baloxavir-Based Combinations and Monotherapies for Treating Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Mice. Local targets link to admitted publications; unresolved targets remain external evidence.
An update on highly pathogenic avian influenza A(H5N1) virus, clade 2.3.4.4b.
10.1093/infdis/jiae379 · 2024 · External reference
Highly pathogenic avian influenza A(H5N1) virus clade 2.3.4.4b infections in wild terrestrial mammals, United States, 2022.
10.3201/eid2912.230464 · 2023 · External reference
Highly pathogenic avian influenza A(H5N1) virus infection in farmed minks, Spain, October 2022.
10.2807/1560-7917.es.2023.28.3.2300001 · 2023 · External reference
A pandemic toolbox for clade 2.3.4.4b A(H5N1) influenza virus risk assessment.
10.1016/j.lanmic.2025.101240 · 2026 · External reference
Influenza virus resistance to neuraminidase inhibitors.
10.1016/j.antiviral.2013.03.014 · 2013 · External reference
Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.
10.1038/s41598-018-27890-4 · 2018 · External reference
Baloxavir and treatment-emergent resistance: public health insights and next steps.
2020 · External reference
Baloxavir improves disease outcomes in mice after intranasal or ocular infection with influenza A virus H5N1-contaminated cow’s milk.
10.1038/s41564-025-01961-5 · 2025 · External reference
Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses from humans in the United States, October 2024 to February 2025.
10.1080/22221751.2025.2601372 · 2026 · External reference
A human isolate of bovine H5N1 is transmissible and lethal in animal models.
10.1038/s41586-024-08254-7 · 2024 · External reference
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice.
10.1038/s41467-026-69721-5 · 2026 · External reference
The toxicity of poisons applied jointly.
10.1111/j.1744-7348.1939.tb06990.x · 1939 · External reference
Unresolved reference
External reference
Antiviral activities of multiple antivirals against highly pathogenic avian influenza A H5N1 in vitro and in mice.
10.1080/22221751.2026.2645843 · 2026 · External reference
The combinatorial activities of oseltamivir and molnupiravir against influenza virus infections in vitro and in vivo.
10.1016/j.virol.2025.110642 · 2025 · External reference
